1. Introduction
Commercial calcium silicate dental materials based upon Portland cement and its constituents are popular options for a variety of dentine substitution, root-end filling and pulp capping indications [
1,
2,
3,
4,
5]. These cements are ‘bioactive’ in that they are capable of forming hydroxyapatite on their surfaces in vivo to support bone, dentine, cementum, periapical tissue and pulp healing [
1,
2,
3,
4,
5].
The composition and properties of Portland cement-based endodontic materials are widely reported in the current literature [
1,
2,
3,
4,
5]. Briefly, Portland cement comprises five phases; alite (tricalcium silicate, Ca
3SiO
5), belite (β-dicalcium silicate, Ca
2SiO
4), aluminate (tricalcium aluminate, Ca
3Al
2O
6), ferrite (tetracalcium aluminoferrite, Ca
2(Al/Fe)
2O
5), and gypsum (calcium sulfate dihydrate, CaSO
4·2H
2O) that react with water to form an adhesive paste that sets into a hardened mass within a few hours and continues to gain compressive strength over a period of weeks [
1,
2,
3,
4,
5]. Alite and belite hydrate to form a nonstoichiometric nanoporous calcium silicate hydrate (C-S-H) gel matrix and hexagonal crystals of calcium hydroxide (aka portlandite). Aluminate and gypsum react with water to form ettringite (AFt, 6CaO·Al
2O
3·3SO
3·32H
2O) which subsequently decomposes to the thermodynamically more stable monosulfate (AFm, 4CaO·Al
2O
3·SO
3·13H
2O) phase [
5]. Ferrite reacts similarly to produce Fe-substituted AFt and AFm phases [
5]. It should be noted that hydraulic calcium silicate dental cements differ from industrial ordinary Portland cements in that their heavy metal content is lower and the particle sizes are smaller [
1,
2,
3,
4,
5]. Also, some calcium silicate dental cements, such as Biodentine
® and Bioaggregate™, are exclusively formulated from alite and belite and do not contain aluminate, ferrite, and gypsum [
1,
2,
3,
4,
5].
Endodontic materials are required to possess a minimum radiopacity equivalent to 3 mm Al [
6], which is achieved by dry-blending the cement with radiopaque barium sulfate or metal oxide compounds of bismuth, zirconium, tantalum, or niobium [
1,
2,
3,
4,
5]. A range of alternative candidate radiopacifying agents, including TiF
4, CaWO
4, Yb
2O
3, YbF
3 and CHI
3, has also been proposed [
7,
8,
9,
10,
11,
12]. Of these, CHI
3 (iodoform) is a common constituent of commercial calcium hydroxide-based pulp capping formulations (e.g., Vitapex
® (Neo Dental International Inc., Federal Way, WA, USA) and Metapex (Meta Biomed, Colmar, PA, USA)). Iodoform is also added to epoxy resin endodontic sealers to confer radiopacity and antimicrobial properties [
13,
14,
15].
In vitro, animal and human studies indicate that iodoform is adequately biocompatible and sufficiently radiopaque at 20 wt% addition to Portland cement to comply with the current regulatory standards for root filling materials (i.e., ISO 6876:2012 [
6] and ANSI/ADA specification #57 [
16]) [
7,
17,
18,
19,
20,
21,
22,
23]. At present, very little is known of the impact of iodoform on the complex hydration and setting reactions of Portland cement. Accordingly, the objectives of this study were to evaluate the effect of 20 wt% addition of iodoform on the hydration, bioactivity, antimicrobial properties and cytotoxicity of white Portland cement (WPC).
The impact of iodoform on the kinetics of the early hydration and setting reactions of the WPC (up to 70 h) were monitored by isothermal conduction calorimetry. The microstructures of the cements were observed by transmission electron microscopy (TEM) with energy dispersive X-ray spectroscopy (EDX) prior to and following the major exothermic reactions (at 3 and 6 h). The longer term development of the hydrated phases within the pure and iodoform-blended cement pastes was evaluated by powder X-ray diffraction analysis (XRD) and
27Al and
29Si magic angle spinning nuclear magnetic resonance spectroscopy (MAS NMR) at 7, 14 and 28 days. The bioactivities of the cements were determined in vitro by immersion in simulated body fluid and a pseudo-second-order kinetic model was used to compare the rates of formation of hydroxyapatite on their surfaces [
24,
25]. The impact of iodoform on the biocompatibility of the cement was assessed using human MG63 osteosarcoma cells and its influence on antimicrobial properties was evaluated using the common pathogens
Staphylococcus aureus,
Pseudomonas aeruginosa and
Escherichia coli.
3. Discussion
Portland cement-based dental materials require the addition of a radiopacifying agent to facilitate their radiographic distinction from the anatomical tissues of the tooth and periradicular structures [
1,
2,
3,
4,
5]. Originally, 20 wt% bismuth oxide was added to the first commercial Portland cement-based root filling material, ProRoot™ MTA (Dentsply Sirona, York, PA, USA), to confer radiopacity. This compound is now widely acknowledged to discolour teeth, delay setting, retard hydration, and to reduce the strength and durability of the resulting cement matrix [
1,
2,
3,
4,
5,
26,
29].
Iodoform is adequately biocompatible with the various dental tissues and has also seen longstanding service as an antimicrobial radiopaque admixture in calcium hydroxide and resin-based root filling and pulp capping materials [
7,
8,
13,
14,
15,
17,
20,
21,
22,
23]. Radiographic studies indicate that 20 wt% replacement iodoform in Portland cement formulations is sufficient to comply with the regulatory radiographic standards for root filling materials [
7,
18,
19,
22], yet very little work has been carried out on the impact of iodoform on the complex hydration chemistry of the cement matrix [
8].
A recent study reports that 20 wt% iodoform reduced the initial and final setting times of white Portland cement from 150 to 121 min and 200 to 165 min, respectively [
8]. Despite this finding, the current research did not identify any significant changes in heat evolution during the first 70 h of white Portland cement hydration in the presence of 20 wt% iodoform, other than a modest reduction in the exotherm arising from renewed ettringite formation (
Figure 1). Initial and final setting times of Portland cements do not directly coincide with any specific chemical reactions or calorimetric events, although both setting times are anticipated to fall within the acceleration phase as the plastic cement matrix becomes rigid and begins to develop mechanical strength [
28]. In this study, the reported initial and final setting times were both found to occur at the beginning of the acceleration phase (
Figure 1) [
8].
The reduced exotherm associated with renewed ettringite formation in the iodoform-blended cement may have arisen from the chemical incorporation of iodine species in this phase, as indicated by TEM-EDX. The TEM-EDX data showed a correlation between the I/Ca and Al/Ca molar ratios of ettringite at 3 and 6 h (
Figure 3). This is also tentatively supported by the marked increase in the size of the ettringite crystals after 3 h in the iodoform-blended sample relative to that of the pure cement paste (
Figure 2). Furthermore, the notable reduction in the relative intensity of the XRD reflections of iodoform in sample WPC-I between 7 and 28 days (
Figure 4b) may also indicate that the iodoform is undergoing chemical reaction within the alkaline environment of the cement matrix. The reactivity of iodoform in the cement system is not unexpected, as halogenoalkanes are acknowledged to participate in nucleophilic substitution of the halide for hydroxide ions under mild alkaline conditions in aqueous media [
43].
Despite its reactivity within the cement matrix, iodoform was found to have no impact on the rate of hydration with respect to the major C-S-H gel product phase (
Table 1). However, it did reduce the substitution of Al for Si in the C-S-H structure at 14 and 28 days. Presumably, the delayed conversion of ettringite to monosulfate in the iodoform-blended cement reduced the concentration of soluble aluminate species available for incorporation into the C-S-H gel during this timeframe.
The two most common radiopacifiers in commercial Portland cement-based dental materials, zirconium oxide (ZrO
2) and bismuth oxide (Bi
2O
3), are known to remain intact and not react or combine with any of the cement phases [
29,
30,
44,
45]. However, despite its lack of chemical reactivity, numerous studies have consistently observed that bismuth oxide prolongs setting times [
9,
29], retards hydration [
29,
44] and alters the calorimetric behaviour [
29] of Portland cement. The specific mechanism of interference of Bi
2O
3 in cement hydration is not known, although it is speculated to arise from poor electrostatic interactions with the cement constituents [
29]. There are conflicting reports in the literature that zirconium oxide retards [
46], accelerates [
45] and has no effect on the setting of Portland cements [
7,
9]. These discrepancies are attributed to differences in particle size and processing history of the ZrO
2 and variations in composition and water:cement ratio of the cement formulations. Conversely, nanoparticulate ZrO
2 is generally accepted to reduce setting times and accelerate hydration via a mechanism known as the ‘filler effect’ [
47]. In spite of the chemical reactivity of iodoform, it appears to have less of an impact on the heat evolution and kinetics of hydration than the nominally inert Bi
2O
3 and ZrO
2 commercial radiopacifiers.
The high alkalinity of Portland cement-based dental materials is considered to impart modest antimicrobial activity. Recent studies have been carried out to enhance the antimicrobial properties of these materials by the incorporation of antibiotic compounds such as chlorhexidine, doxycycline and cetrimide [
48,
49,
50,
51]. To date, no studies have been conducted to investigate any changes to the chemistry and microstructure of the cements in the presence of these small organic molecules, so a direct comparison with the results obtained here for the incorporation of iodoform is not currently possible. However, 0.2 wt% chlorhexidine is reported to have a significantly negative impact on calcified bridge formation in the direct pulp capping of dog’s teeth [
48]. The minimal reduction in cytocompatibility (
Table 4) and bioactivity (
Figure 7,
Figure 8 and
Figure 9) observed for the iodoform-blended cement may represent potential advantages worthy of further histological investigation.
The specific mechanisms by which iodoform exerts microbial disinfection are unclear; although, it has been proposed that free iodine is released which oxidatively denatures bacterial proteins and also reacts with unsaturated lipids to disrupt the cell membrane [
52]. A previous ‘zone of inhibition’ study [
8] demonstrated that 20 wt% iodoform significantly enhanced the intrinsic antimicrobial effect of Portland cement against
S. aureus,
P. aeruginosa and
E. coli, indicating that antimicrobial iodine species are released from the cement matrix to diffuse through the agar medium. The present research has also confirmed the release of iodine species from the blended cement in SBF (
Figure 8) and has shown that the minimum bactericidal concentration of the blended cement is significantly lower than that of pure Portland cement against all three pathogens (
Table 3).
From a clinical perspective, the enhanced antimicrobial activity with no significant concomitant reduction in bioactivity or cytotoxicity associated with the incorporation of iodoform in Portland cement is clearly advantageous. Whether the observed compositional changes in the AFt, AFm and C-S-H phases and ongoing dissolution of iodine species would have a significant impact on the durability of the cement matrix is unknown. Hence, some caution is warranted for long-term clinical applications of iodoform-blended Portland cements. This notwithstanding, a recent 24-month clinical trial with radiographic assessments on Portland cement mixed with either 20 wt% ZrO
2 or iodoform for primary molar pulpotomies showed no statistically significant differences in the outcomes between the two radiopacifiers indicating satisfactory clinical performance [
22].
4. Materials and Methods
4.1. Materials and Sample Preparation
The oxide and calculated Bogue compositions (i.e., proportions of phases present) of the white Portland cement (ex. Lafarge, Gravesend, UK) used in this study were provided by the manufacturer and are listed in
Table 5. All other reagents were purchased from Sigma-Aldrich (Gillingham, UK) and used without further purification or modification.
White Portland cement (WPC) paste samples were prepared by manually mixing 10 g of cement with 3.5 g of distilled water for 5 min with a polypropylene spatula. Samples blended with 20 wt% iodoform (namely, WPC-I) were prepared similarly with partial replacement of 2 g of the WPC by reagent grade CHI3 at a water:solid ratio of 0.28 (i.e., a water:cement ratio of 0.35). The resulting pastes were sealed in polypropylene containers and cured at 37 °C until required. Prior to analysis by powder XRD, 27Al and 29Si MAS NMR and FTIR, the hydration reactions were stopped by solvent exchange with propan-2-ol. This was achieved by immersion of twenty 2 mm fragments of the pastes in four consecutive 50 cm3 washings of propan-2-ol in a sonic bath for 30 min. The samples were then dried to constant mass in a vacuum desiccator at room temperature.
4.2. Isothermal Conduction Calorimetry
The rates of heat evolution during hydration of samples WPC and WPC-I were measured by isothermal conduction calorimetry using a Thermometric 2277 TAM calorimeter (Thermometric AB, Stockholm, Sweden) at 37.5 °C (i.e., body temperature). In triplicate, approximately 0.05 g of accurately weighed freshly mixed cement paste were placed in the calorimeter. Power data were collected every second for 70 h, and the rate of heat evolution per unit gram of cement powder was then calculated by dividing the power data by the original mass of white Portland cement in the paste.
4.3. Transmission Electron Microscopy with Energy Dispersive X-Ray Analysis
TEM-EDX analysis of the early hydration products of WPC and WPC-I after hydration for 3 and 6 h at 37 °C in sealed polypropylene containers were obtained by dispersing the sample in methanol prior to deposition onto a carbon film grid. Bright field images were obtained using a JEOL JEM200CX microscope at 200 kV equipped with a Gata Orius SC200 digital camera (JEOL, Tokyo, Japan).
4.4. Powder X-ray Diffraction Analysis
Powder XRD analysis was carried out on specimens WPC and WPC-I after 7, 14 and 28 days of hydration. Diffraction patterns were obtained using a Bruker D8 diffractometer (Bruker AXS, Karlsruhe, Germany) with Cu Kα = 1.5406 Å, a step size of 0.019 ° in the 2θ range from 5 to 50 ° and a measuring time of 1 s per step. Phase identification was carried out using Powder Diffraction Files (PDF®) on DIFFRAC.EVA software (Bruker AXS, Karlsruhe, Germany).
4.5. 27Al and 29Si Nuclear Magnetic Resonance Spectroscopy
27Al and 29Si MAS NMR spectra were collected using a JEOL JNM-ECX 300 MHz spectrometer (JEOL (UK) Ltd., Welwyn Garden City, UK). Single pulse 27Al MAS NMR spectra were referenced to the aluminium hexaquo-ion, [Al (H2O)6], and obtained with a pulse delay of 0.5 s, an acquisition time of 0.01024 s and 8000 scans. Single pulse 29Si MAS NMR spectra were referenced to tetramethylsilane (TMS) and obtained with a pulse delay of 5 s, an acquisition time of 0.02048 s, and 65,000 scans. The free induction decay profiles were processed by Delta software (provided by JEOL) to obtain spectra which were then analysed using Igor Pro software (WaveMetrics Inc., Portland, OR, USA).
The
29Si MAS NMR spectra were analysed by a method reported by Love et al. [
31]. The signal from unreacted alite that obscures the resonances of the hydrated monomers and dimers was subtracted from the spectrum prior to deconvolution. This was accomplished by adjusting the intensity of the anhydrous WPC spectrum to match the intensity of the alite signal in the hydrated spectrum. The adjusted WPC spectrum was then subtracted from that of the hydrated sample prior to deconvolution using iterative fitting of the Q
0(H), Q
1, Q
2 and Q
2(1Al)
29Si resonances to Voigt lineshapes. The concentrations of the various Q
n species, degree of hydration, mean silicate chain length (MCL) and Al/Si ratio were then calculated from the subtracted and deconvoluted spectra [
32,
33]. The formulae for the calculations of degree of hydration, MCL and Al/Si ratio are given below [
31,
33], where Q
n represents the intensity of the
29Si MAS NMR signal corresponding to the relevant silicate species:
4.6. In Vitro Bioactivity
Simulated body fluid (SBF) was prepared in accordance with the method described in reference 24 and used immediately. 0.15 g of either WPC or WPC-I were contacted with 150 cm3 of SBF in hermetically sealed polypropylene containers at 37 °C for 3, 6, 24, 44, 72 and 168 h. Each analysis was carried out in triplicate. Solution concentrations of Ca, P, Si and I species were analysed by inductively coupled plasma analysis optical emission spectroscopy (ICP-OES) using a TJA Iris simultaneous ICP-OES spectrometer (TJA, MA, USA) and multi-element standards matrix-matched with sodium chloride. The relative standard deviations of the means of the concentrations of the various components were less than 7%. Differences in the concentrations of components in the SBF solutions in contact with WPC and WPC-I were subjected to two-tailed t-tests at p = 0.05. The solid specimens were recovered by filtration after 3, 6 and 24 h, washed once with distilled water, and dried in air at 37 °C for 24 h prior to analysis by FTIR using a PerkinElmer Paragon 1000 FTIR spectrophotometer to confirm the formation of a layer of hydroxyapatite. Spectra were recorded between 4000 and 500 cm−1 using pressed KBr discs.
The uptake of HPO
42− ions during the precipitation of hydroxyapatite on the surfaces of WPC and WPC-I was modelled using the pseudo-second-order rate expression Equation (4) [
25], where
k2 is the apparent pseudo-second-order rate constant (in g mg
−1 min
−1),
qt is the extent of sorption at time
t (in mg g
−1), and
qe is the extent of sorption at equilibrium (in mg g
−1):
Estimates of k2 and qe for the uptake of HPO42− ions by WPC and WPC-I were derived from the intercept and gradient of a linear plots of t/qt against t. In both cases, the product moment correlation coefficient, R2, was estimated as an indication of goodness of fit, and the difference between k2 values for WPC and WPC-I were tested using a two-tailed t-test at p = 0.05.
4.7. Antimicrobial Activity
Overnight cultures of
Staphylococcus aureus (NCIMB 9518),
Pseudomonas aeruginosa (NCIMB 8628) and
Escherichia coli (NCIMB 9001) were grown in separate McCartney bottles containing 10 cm
3 of nutrient broth (Oxoid). Cement samples, WPC and WPC-I, were prepared according to the method described in
Section 4.1 and cured for 6 h prior to grinding with a mortar and pestle and passing through a 1 mm sieve. WPC or WPC-I at concentrations of 50, 100 and 150 mg were added separately to McCartney bottles containing 9 cm
3 of nutrient broth. These tubes were inoculated with cultures of
S. aureus,
P. aeruginosa or
E. coli to densities of 1.9 × 10
5, 9.5 × 10
5 and 4.2 × 10
4 colony forming units per cm
3 (CFU cm
−3), respectively. Each assay was carried out in triplicate. The cultures were then incubated, with shaking, at 37 °C overnight and duplicate plate counts on nutrient broth (Oxoid) were taken for each assay.
4.8. Biocompatibility
The in vitro biocompatibilities of WPC and WPC-I were evaluated using MG63 human osteosarcoma cells (ECACC code: 86051601) as described in reference [
53]. In quadruplicate, WPC and WPC-I cement samples were cast into 24-well plates and sterilised via UV irradiation for 3 h on each side. MG63 cells were harvested from the main culture at low-passage (<10) at confluency of 80–90% and >90% viability. They were suspended in fresh media and added to the cement-containing wells at 1 × 10
4 cells/well and 2 cm
3 total volume. The cells were then incubated for 24 h. An MTT (3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide) analysis was conducted to evaluate the toxicity of the cements. The original media was decanted off and 2 cm
3 of fresh media were added per well. Then, 0.4 cm
3 of filter-sterilised solution of 25 mg of MTT in 50 cm
3 of 0.01 M PBS solution were placed in each well and incubated for four hours at 37 °C and 5% CO
2. The media was decanted off, 2 cm
3 of DMSO were added and the plates were incubated at room temperature for 30 min. 0.2 cm
3 of each solution was put onto a 96-well plate and the absorbance was read at 540 nm using a Multiskan Ascent microplate photometer plate reader (Thermoelectron Corporation, Thermoscientific, UK). The control consisted of wells with media only whose absorbance was subtracted from those of the wells containing the cements and cells. The absorbance data were subjected to a two-tailed
t-test at (
n-2) degrees of freedom. The null hypothesis was tested at
p = 0.05.